Lumos Diagnostics Director Increases Shareholding

Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.

Lumos Diagnostics Holdings Ltd. has issued a notice indicating a change in the interests of director Sam Lanyon, who through indirect interests, acquired 137,362 fully paid ordinary shares at a valuation of $5,219.76. This change is due to a pro-rata accelerated non-renounceable entitlement offer, resulting in a consolidated total of 1,116,729 shares and 2,246,500 unquoted options held by Sicksamba Pty Ltd.

For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.